/Investor DB

Milford Private Equity

Institutional investor

Auckland · Growth–Late Stage · 77 people tracked

Find your way into Milford Private Equity

Sign up to see every warm intro you have to Milford Private Equity

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Milford Private Equity team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

✨ Fox Verdict
Sign up to see your fit

Investment thesis

Milford applies an ESG-focused investment approach, conducting in-depth analysis of the environmental, social and governance credentials of every company it invests in. The firm believes it can make the greatest impact by actively engaging with companies to address sustainability issues and drive positive change. Companies that fail to meet the firm's minimum standards of sustainable practice are added to an exclusion list.

Source: firm website, verified Sep 26, 2026.

Stage
Growth–Late Stage
HQ
Auckland, NZ
Instruments
Equity

Team · 77 people

from the firm's website

Frequently asked questions

What stage does Milford Private Equity invest at?
Milford Private Equity invests at the Growth, Late Stage stages.
What sectors does Milford Private Equity focus on?
Milford Private Equity focuses on Impact & Social Good, Sector Agnostic.
Where is Milford Private Equity located?
Milford Private Equity is headquartered in Auckland, NZ.

Media · Podcasts & interviews

from their channel

EP95: US debt, oil shocks and the risks testing global markets

Milford

EP94: What award recognition means for your KiwiSaver choice

Milford

EP93: Do elections actually matter for investors?

Milford

EP92: What happens when company values are put to the test?

Milford

Stock Story: Eli Lilly

Milford

EP91: Could Moderna's mRNA breakthrough transform cancer treatment?

Milford

Similar investors

Featured in lists